Esbriet (pirfenidone) is a prescription drug used to treat idiopathic pulmonary fibrosis. Esbriet’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy ...
Esbriet (pirfenidone) is a prescription drug that’s used to treat a lung condition called idiopathic pulmonary fibrosis. The drug comes as an oral tablet and capsule. It’s usually taken three times ...
InterMune announced new analyses of data from the RECAP extension study of Esbriet (pirfenidone), being studied for the treatment of idiopathic pulmonary fibrosis (IPF). RECAP is an open-label ...
BRISBANE, Calif., Oct. 2, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Health Canada has approved Esbriet® (pirfenidone) for the treatment of mild to moderate idiopathic ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Logo of Swiss drugmaker Roche is seen in Basel ZURICH (Reuters) - Roche has won U.S. breakthrough therapy status for ...
Esbriet (pirfenidone) is a brand-name drug that’s prescribed for a certain lung condition. Esbriet has interactions with some other drugs. Examples include cimetidine (Tagamet HB) and certain blood ...
(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).
Esbriet is marketed for treating adults suffering from mild-to-moderate idiopathic pulmonary fibrosis (IPF), a rare and fatal lung disease. The decision of the CEPS makes Esbriet the first drug to be ...
New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030 ...
After whittling down Genentech’s defenses at a bench trial last fall, Novartis’ Sandoz unit has removed a major hurdle on the path to launching its Esbriet copycat. A Delaware federal judge has ...
Esbriet (pirfenidone) is a brand-name drug prescribed for pulmonary fibrosis in adults. Esbriet comes as an oral capsule or tablet that’s typically taken three times per day. Dosage can vary depending ...
New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results